Atossa Therapeutics (ATOS) Short Interest Ratio & Short Volume → The only AI company you should be looking at (From Behind the Markets) (Ad) Free ATOS Stock Alerts $1.29 0.00 (0.00%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Atossa Therapeutics Short Interest DataCurrent Short Volume7,150,000 sharesPrevious Short Volume7,040,000 sharesChange Vs. Previous Month+1.56%Dollar Volume Sold Short$6.99 millionShort Interest Ratio / Days to Cover13.6Last Record DateFebruary 29, 2024Outstanding Shares125,300,000 sharesPercentage of Shares Shorted5.71%Today's Trading Volume817,518 sharesAverage Trading Volume599,903 sharesToday's Volume Vs. Average136% Short Selling Atossa Therapeutics ? Sign up to receive the latest short interest report for Atossa Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATOS Short Interest Over TimeATOS Days to Cover Over TimeATOS Percentage of Float Shorted Over Time Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Atossa Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20247,150,000 shares $6.99 million +1.6%N/A13.6 $0.98 2/15/20247,040,000 shares $7.11 million +2.9%N/A16.8 $1.01 1/31/20246,840,000 shares $5.84 million -2.2%N/A17.4 $0.85 1/15/20246,990,000 shares $6.36 million +9.9%N/A18.4 $0.91 12/31/20236,360,000 shares $5.60 million +1.0%N/A16.7 $0.88 12/15/20236,300,000 shares $4.67 million +1.0%N/A19.3 $0.74 Get the Latest News and Ratings for ATOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20236,240,000 shares $4.64 million -2.0%N/A19.3 $0.74 11/15/20236,370,000 shares $4.17 million -4.2%N/A17.4 $0.65 10/31/20236,650,000 shares $4.46 million -5.7%N/A16.4 $0.67 10/15/20237,050,000 shares $4.65 million -2.8%N/A16.3 $0.66 9/30/20237,250,000 shares $5.34 million -8.8%N/A13.1 $0.74 9/15/20237,950,000 shares $6.28 million -3.1%N/A9.7 $0.79 8/31/20238,200,000 shares $6.48 million -1.8%N/A9.6 $0.79 8/15/20238,350,000 shares $7.36 million -1.7%N/A8.6 $0.88 7/31/20238,490,000 shares $9.34 million -2.6%N/A9.1 $1.10 7/15/20238,720,000 shares $10.81 million +12.5%N/A9.5 $1.24 6/30/20237,750,000 shares $9.77 million +6.9%N/A9.8 $1.26 6/15/20237,250,000 shares $6.52 million -3.6%N/A14.4 $0.90 5/31/20237,520,000 shares $6.99 million -3.2%N/A16.1 $0.93 5/15/20237,770,000 shares $5.50 million -3.7%N/A22.4 $0.71 4/30/20238,070,000 shares $5.16 million -3.1%N/A24.9 $0.64 4/15/20238,330,000 shares $6.12 million -1.3%N/A24.4 $0.74 3/31/20238,440,000 shares $6.12 million -1.9%N/A19.4 $0.72 3/15/20238,600,000 shares $5.59 million +0.6%N/A17.1 $0.65 2/28/20238,550,000 shares $6.33 million -2.2%N/A15.5 $0.74 2/15/20238,740,000 shares $6.69 million -0.6%N/A15.9 $0.77 1/31/20238,790,000 shares $7.04 million -3.2%N/A15.6 $0.80 1/15/20239,080,000 shares $7.75 million -1.7%N/A15.5 $0.85 12/30/20229,240,000 shares $4.88 million -3.7%N/A18.1 $0.53 12/15/20229,590,000 shares $5.61 million -4.3%N/A21.2 $0.59 11/30/202210,020,000 shares $7.52 million -4.1%N/A22.4 $0.75 11/15/202210,450,000 shares $8.58 million -0.2%N/A23.7 $0.82 10/31/202210,470,000 shares $10.32 million -1.2%N/A19.5 $0.99 10/15/202210,600,000 shares $8.59 million -5.8%N/A19.2 $0.81 9/30/202211,250,000 shares $9.37 million -1.6%N/A18.9 $0.83 9/15/202211,430,000 shares $10.53 million -2.8%N/A11.8 $0.92 8/31/202211,760,000 shares $10.83 million -1.3%N/A10.1 $0.92 8/15/202211,910,000 shares $13.58 million -3.7%N/A9 $1.14 7/31/202212,370,000 shares $11.64 million -1.9%N/A8.9 $0.94 7/15/202212,610,000 shares $12.99 million -3.7%N/A7.9 $1.03Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ATOS Short Interest - Frequently Asked Questions What is Atossa Therapeutics' current short interest? Short interest is the volume of Atossa Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 7,150,000 shares of ATOS short. Learn More on Atossa Therapeutics' current short interest. What is a good short interest ratio for Atossa Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATOS shares currently have a short interest ratio of 14.0. Learn More on Atossa Therapeutics's short interest ratio. Which institutional investors are shorting Atossa Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Atossa Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Atossa Therapeutics' short interest increasing or decreasing? Atossa Therapeutics saw a increase in short interest in February. As of February 29th, there was short interest totaling 7,150,000 shares, an increase of 1.6% from the previous total of 7,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Atossa Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Atossa Therapeutics: Nektar Therapeutics (1.11%), Adicet Bio, Inc. (8.07%), ProQR Therapeutics (0.57%), Relmada Therapeutics, Inc. (5.81%), Karyopharm Therapeutics Inc. (20.37%), GlycoMimetics, Inc. (2.42%), Spyre Therapeutics, Inc. (6.69%), Immuneering Co. (12.64%), G1 Therapeutics, Inc. (5.57%), Rani Therapeutics Holdings, Inc. (15.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Atossa Therapeutics stock? Short selling ATOS is an investing strategy that aims to generate trading profit from Atossa Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atossa Therapeutics? A short squeeze for Atossa Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATOS, which in turn drives the price of the stock up even further. How often is Atossa Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATOS, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Nektar Therapeutics Short Interest Adicet Bio Short Interest ProQR Therapeutics Short Interest Relmada Therapeutics Short Interest Karyopharm Therapeutics Short Interest GlycoMimetics Short Interest Spyre Therapeutics Short Interest Immuneering Short Interest G1 Therapeutics Short Interest Rani Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATOS) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company